Onychomycosis Drug Market

Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.

Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.

Onychomycosis Drug Market contains market size and forecasts of Onychomycosis (Tinea Unguium) Drug in Global, including the following market information:

Global Onychomycosis (Tinea Unguium) Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Onychomycosis (Tinea Unguium) Drug market was valued at 3383.2 million in 2021 and is projected to reach US$ 4938 million by 2028, at a CAGR of 5.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Onychomycosis (Tinea Unguium) Drug include Pfizer, Yangtze River, Torrent Pharma, J&J, Chengdu Brilliant, Novartis, Qilu Pharmaceutical, Xiuzheng Pharmaceutical and Hubei Hengan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Onychomycosis (Tinea Unguium) Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Onychomycosis (Tinea Unguium) Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Onychomycosis (Tinea Unguium) Drug Market Segment Percentages, by Type, 2021 (%)

• Oral Medication
• External Medicine

Global Onychomycosis (Tinea Unguium) Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Onychomycosis (Tinea Unguium) Drug Market Segment Percentages, by Application, 2021 (%)

• Age under 18
• Age 18-50
• Age above 50

Global Onychomycosis (Tinea Unguium) Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Onychomycosis (Tinea Unguium) Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Onychomycosis (Tinea Unguium) Drug revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Onychomycosis (Tinea Unguium) Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Yangtze River
• Torrent Pharma
• J&J
• Chengdu Brilliant
• Novartis
• Qilu Pharmaceutical
• Xiuzheng Pharmaceutical
• Hubei Hengan
• TARO
• Perrigo
• Galderma pharm
• Zhejiang Deyer
• Valeant Pharma
• Moberg